Relationships of serum levels of tocilizumab to interleukin-6 and endogenous markers of CYP3A activity in patients with rheumatoid arthritis.

Saved in:
Bibliographic Details
Title: Relationships of serum levels of tocilizumab to interleukin-6 and endogenous markers of CYP3A activity in patients with rheumatoid arthritis.
Authors: Mochizuki T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan., Shibata K; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Department of Pharmacy, Shinshu University Hospital, Nagano, Japan., Naito T; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Department of Pharmacy, Shinshu University Hospital, Nagano, Japan., Shimoyama K; Department of Internal Medicine Ⅲ, Hamamatsu University School of Medicine, Hamamatsu, Japan., Ogawa N; Department of Internal Medicine Ⅲ, Hamamatsu University School of Medicine, Hamamatsu, Japan., Kawakami J; Department of Hospital Pharmacy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Source: Annals of clinical biochemistry [Ann Clin Biochem] 2026 Jan; Vol. 63 (1), pp. 49-57. Date of Electronic Publication: 2025 Jun 25.
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 0324055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1001 (Electronic) Linking ISSN: 00045632 NLM ISO Abbreviation: Ann Clin Biochem Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-1001
DOI:10.1177/00045632251357148